S&P 500   4,605.23 (+0.02%)
DOW   36,344.14 (+0.27%)
QQQ   394.32 (+0.55%)
AAPL   192.14 (-1.82%)
MSFT   370.07 (-1.11%)
META   321.77 (-3.30%)
GOOGL   132.24 (-2.04%)
AMZN   144.77 (-1.80%)
TSLA   241.82 (-0.83%)
NVDA   462.44 (-2.66%)
NIO   7.45 (+0.95%)
BABA   71.48 (-0.91%)
AMD   133.83 (+3.81%)
T   16.66 (-1.54%)
F   11.09 (+0.73%)
MU   77.77 (+3.75%)
CGC   0.81 (+1.53%)
GE   120.47 (-0.10%)
DIS   92.79 (-0.03%)
AMC   6.81 (-1.73%)
PFE   28.51 (-0.94%)
PYPL   59.55 (+1.03%)
XOM   99.25 (-0.30%)
S&P 500   4,605.23 (+0.02%)
DOW   36,344.14 (+0.27%)
QQQ   394.32 (+0.55%)
AAPL   192.14 (-1.82%)
MSFT   370.07 (-1.11%)
META   321.77 (-3.30%)
GOOGL   132.24 (-2.04%)
AMZN   144.77 (-1.80%)
TSLA   241.82 (-0.83%)
NVDA   462.44 (-2.66%)
NIO   7.45 (+0.95%)
BABA   71.48 (-0.91%)
AMD   133.83 (+3.81%)
T   16.66 (-1.54%)
F   11.09 (+0.73%)
MU   77.77 (+3.75%)
CGC   0.81 (+1.53%)
GE   120.47 (-0.10%)
DIS   92.79 (-0.03%)
AMC   6.81 (-1.73%)
PFE   28.51 (-0.94%)
PYPL   59.55 (+1.03%)
XOM   99.25 (-0.30%)
S&P 500   4,605.23 (+0.02%)
DOW   36,344.14 (+0.27%)
QQQ   394.32 (+0.55%)
AAPL   192.14 (-1.82%)
MSFT   370.07 (-1.11%)
META   321.77 (-3.30%)
GOOGL   132.24 (-2.04%)
AMZN   144.77 (-1.80%)
TSLA   241.82 (-0.83%)
NVDA   462.44 (-2.66%)
NIO   7.45 (+0.95%)
BABA   71.48 (-0.91%)
AMD   133.83 (+3.81%)
T   16.66 (-1.54%)
F   11.09 (+0.73%)
MU   77.77 (+3.75%)
CGC   0.81 (+1.53%)
GE   120.47 (-0.10%)
DIS   92.79 (-0.03%)
AMC   6.81 (-1.73%)
PFE   28.51 (-0.94%)
PYPL   59.55 (+1.03%)
XOM   99.25 (-0.30%)
S&P 500   4,605.23 (+0.02%)
DOW   36,344.14 (+0.27%)
QQQ   394.32 (+0.55%)
AAPL   192.14 (-1.82%)
MSFT   370.07 (-1.11%)
META   321.77 (-3.30%)
GOOGL   132.24 (-2.04%)
AMZN   144.77 (-1.80%)
TSLA   241.82 (-0.83%)
NVDA   462.44 (-2.66%)
NIO   7.45 (+0.95%)
BABA   71.48 (-0.91%)
AMD   133.83 (+3.81%)
T   16.66 (-1.54%)
F   11.09 (+0.73%)
MU   77.77 (+3.75%)
CGC   0.81 (+1.53%)
GE   120.47 (-0.10%)
DIS   92.79 (-0.03%)
AMC   6.81 (-1.73%)
PFE   28.51 (-0.94%)
PYPL   59.55 (+1.03%)
XOM   99.25 (-0.30%)

Health Catalyst (HCAT) Stock Price, News & Analysis

$7.40
-0.36 (-4.64%)
(As of 11:04 AM ET)
Compare
Today's Range
$7.35
$7.66
50-Day Range
$6.71
$10.16
52-Week Range
$6.60
$15.87
Volume
104,481 shs
Average Volume
479,310 shs
Market Capitalization
$425.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.40

Health Catalyst MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
79.9% Upside
$13.40 Price Target
Short Interest
Healthy
2.99% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.91
Upright™ Environmental Score
News Sentiment
0.00mentions of Health Catalyst in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$38,879 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.90) to ($0.88) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.37 out of 5 stars

Medical Sector

283rd out of 942 stocks

Health Information Services Industry

3rd out of 7 stocks


HCAT stock logo

About Health Catalyst Stock (NASDAQ:HCAT)

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinical and quality, population health, and financial and operational use cases. It also provides services expertise, which include data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.

HCAT Stock Price History

HCAT Stock News Headlines

Portland health care AI startup names new CEO
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Health Catalyst (HCAT) Stock Trades Up, Here Is Why
All the trading advice you’ve ever received boils down to this
All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.
Health Catalyst Reports Third Quarter 2023 Results
Health Catalyst raises FY revenue outlook
Health Catalyst Insider Ups Holding By 42% During Year
See More Headlines
Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/02/2023
Today
12/11/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/27/2024

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HCAT
Fax
N/A
Employees
1,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.40
High Stock Price Target
$18.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+72.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
10 Analysts

Profitability

Net Income
$-137,400,000.00
Pretax Margin
-42.53%

Debt

Sales & Book Value

Annual Sales
$276.24 million
Book Value
$7.76 per share

Miscellaneous

Free Float
55,996,000
Market Cap
$446.59 million
Optionable
Not Optionable
Beta
1.29
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report














HCAT Stock Analysis - Frequently Asked Questions

Should I buy or sell Health Catalyst stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last twelve months. There are currently 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HCAT shares.
View HCAT analyst ratings
or view top-rated stocks.

What is Health Catalyst's stock price target for 2024?

10 brokers have issued 1-year price targets for Health Catalyst's shares. Their HCAT share price targets range from $8.00 to $18.00. On average, they expect the company's share price to reach $13.40 in the next year. This suggests a possible upside of 79.9% from the stock's current price.
View analysts price targets for HCAT
or view top-rated stocks among Wall Street analysts.

How have HCAT shares performed in 2023?

Health Catalyst's stock was trading at $10.63 at the beginning of the year. Since then, HCAT shares have decreased by 29.9% and is now trading at $7.45.
View the best growth stocks for 2023 here
.

Are investors shorting Health Catalyst?

Health Catalyst saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 1,720,000 shares, an increase of 13.9% from the October 31st total of 1,510,000 shares. Based on an average trading volume of 466,800 shares, the days-to-cover ratio is presently 3.7 days.
View Health Catalyst's Short Interest
.

When is Health Catalyst's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our HCAT earnings forecast
.

How were Health Catalyst's earnings last quarter?

Health Catalyst, Inc. (NASDAQ:HCAT) issued its quarterly earnings data on Thursday, November, 2nd. The company reported ($0.22) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.05. The business had revenue of $73.77 million for the quarter, compared to analysts' expectations of $72.73 million. Health Catalyst had a negative net margin of 42.62% and a negative trailing twelve-month return on equity of 14.08%.

What guidance has Health Catalyst issued on next quarter's earnings?

Health Catalyst issued an update on its third quarter 2023 earnings guidance on Friday, October, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $73.77 million-$73.77 million, compared to the consensus revenue estimate of $72.66 million.

What is Dan Burton's approval rating as Health Catalyst's CEO?

501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend.

What other stocks do shareholders of Health Catalyst own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL).

When did Health Catalyst IPO?

(HCAT) raised $129 million in an IPO on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair served as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

Who are Health Catalyst's major shareholders?

Health Catalyst's stock is owned by a number of retail and institutional investors. Top institutional investors include JPMorgan Chase & Co. (3.44%), Primecap Management Co. CA (1.95%), Nepsis Inc. (1.59%), Bank of New York Mellon Corp (1.50%), Jacobs Levy Equity Management Inc. (1.33%) and Bares Capital Management Inc. (1.22%). Insiders that own company stock include Anita Pramoda, Benjamin Landry, Bryan Richard Hinton, Bryan Truman Hunt, Daniel D Burton, Daniel H Orenstein, Duncan Gallagher, James Patrick Jr Nelli, Jason Alger, Linda Llewelyn, Paul Horstmeier and Timothy G Ferris.
View institutional ownership trends
.

How do I buy shares of Health Catalyst?

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:HCAT) was last updated on 12/11/2023 by MarketBeat.com Staff

My Account -